SALVATORELLI, EMANUELA
 Distribuzione geografica
Continente #
EU - Europa 23
Totale 23
Nazione #
IT - Italia 23
Totale 23
Città #
Rome 23
Totale 23
Nome #
Further analytical, pharmacokinetic, and clinical observations on low-dose ponatinib in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, file de024af2-6847-70dc-e053-6605fe0a0424 7
Anthracycline Cardiotoxicity, file de024af2-2136-70dc-e053-6605fe0a0424 3
Modeling human myocardium exposure to doxorubicin defines the risk of heart failure from low-dose doxorubicin, file 3e4965d3-f48a-462c-b2db-52391c48f607 2
Anthracyclines and Cardiotoxicity: Is CARP a Forgotten Biomarker?, file 84b64077-5056-42e8-820a-c40aaa0ae365 2
CARDIAC ANTHRACYCLINE ACCUMULATION AND B-TYPE NATRIURETIC PEPTIDE TO DEFINE RISK AND PREDICTORS OF CANCER TREATMENT RELATED EARLY DIASTOLIC DYSFUNCTION, file a0fad69f-cbe2-45ac-b00a-22001dd32221 2
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin, file de024af2-067c-70dc-e053-6605fe0a0424 2
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial, file de024af2-624a-70dc-e053-6605fe0a0424 2
Modeling human myocardium exposure to doxorubicin defines the risk of heart failure from low-dose doxorubicin, file de024af2-6ca8-70dc-e053-6605fe0a0424 2
Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin, file de024af2-b8d4-70dc-e053-6605fe0a0424 2
Doxorubicin-Dependent Reduction of Ferrylmyoglobin and Inhibition of Lipid Peroxidation: Implications for Cardiotoxicity of Anticancer Anthracyclines, file de024af2-b8d8-70dc-e053-6605fe0a0424 2
The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: Insight to explain the cardiac safety of pixantrone in doxorubicin treated patients, file de024af2-0178-70dc-e053-6605fe0a0424 1
Cardiotoxicity of targeted cancer drugs: concerns, “The cart before the horse,” and lessons from trastuzumab, file de024af2-07fb-70dc-e053-6605fe0a0424 1
Doxorubicin irreversibly inactivates iron regulatory protein-1 and –2 in cardiomyocytes: evidence for distinct metabolic pathways and implication for iron-mediated cardiotoxicity of antitumor therapy, file de024af2-09d6-70dc-e053-6605fe0a0424 1
Anthracyclines, file de024af2-107b-70dc-e053-6605fe0a0424 1
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox, file de024af2-19f1-70dc-e053-6605fe0a0424 1
Managing anthracycline-induced cardiotoxicity: beginning with the end in mind, file de024af2-35fe-70dc-e053-6605fe0a0424 1
What is cardiotoxicity?, file de024af2-36e4-70dc-e053-6605fe0a0424 1
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin, file de024af2-63fb-70dc-e053-6605fe0a0424 1
Defective taxane stimulation of epirubicinol formation in the human heart: Insights into the cardiac tolerability of epirubicin-taxane chemotherapies, file de024af2-73cd-70dc-e053-6605fe0a0424 1
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues., file de024af2-7a99-70dc-e053-6605fe0a0424 1
Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis, file de024af2-82dd-70dc-e053-6605fe0a0424 1
Beyond hypertension: Diastolic dysfunction associated with cancer treatment in the era of cardio-oncology, file de1baa08-f29f-445f-9757-bd93702b8dc5 1
Totale 38
Categoria #
all - tutte 67
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 1 1 0 0 0 0 13 0 0 1 0
2022/202319 0 0 0 0 0 0 2 0 2 5 3 7
2023/20243 0 1 0 0 0 2 0 0 0 0 0 0
Totale 38